LL22NC03-N64E9.1 could epigenetically suppress the expression of KLF2 by binding to EZH2 (one key components of PRC2), thus promoting CRC development. (28938648)
user: 0
Pubmeds:
Login
For any questions and suggestions, write to us by mail: info@onco.io